Also known as Thymosin beta-4
Caution. Not broadly approved for general use.
Thymosin beta-4 is an endogenous actin-sequestering peptide that regulates cell motility, cytoskeletal dynamics, and tissue repair. Preclinical and limited clinical work links it to improved wound healing, angiogenesis, and reduced fibrosis. Most human data are from small studies or specific indications rather than broad therapeutic use, and it is not approved for general medical use.
Checked Jul 15, 2026.
Stack logs each dose you take, tracks what is left in the vial or bottle and shows how you kept to your plan. It records what you choose and does not recommend anything. Everything stays on your phone, with no account.
Get Stack on Google Play Peptide reconstitution calculatorThis entry summarises published information in plain language. It is not medical advice, a dosing recommendation or a substitute for a qualified healthcare professional. Many peptides are not approved for human use, and legal status varies by country. Check anything you rely on against primary sources.